The metabolic syndrome in older persons

Clinics in Geriatric Medicine

Volumn 26, Issue 2, 2010, Pages 261-274

  Sinclair, Alan ^a   Viljoen, Adie ^a,b  

^a UNIVERSITY OF BEDFORDSHIRE   (United Kingdom)

^b LISTER HOSPITAL   (United Kingdom)

Author keywords

Aged; Diabetes; Elderly; Metabolic syndrome

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 6; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN; MELANOCORTIN 4 RECEPTOR; PARATHYROID HORMONE; PLASMINOGEN ACTIVATOR INHIBITOR 1; TESTOSTERONE; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; URIC ACID; VITAMIN D;

AGE; ANDROGEN THERAPY; CALORIC INTAKE; CARDIOVASCULAR RISK; CLINICAL DECISION MAKING; ENVIRONMENTAL CHANGE; ENVIRONMENTAL FACTOR; ETHNIC DIFFERENCE; GENETIC ASSOCIATION; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HUMAN; HYPERINSULINEMIA; HYPOGONADISM; INSULIN RESISTANCE; LIPOGENESIS; METABOLIC SYNDROME X; OXIDATIVE STRESS; PATHOGENESIS; PHYSICAL ACTIVITY; REVIEW; RISK REDUCTION; TESTOSTERONE BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID URINE LEVEL; VITAMIN DEFICIENCY;

AGE FACTORS; AGED; AGED, 80 AND OVER; AGING; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; GERIATRICS; HUMANS; INTRA-ABDOMINAL FAT; MALE; METABOLIC SYNDROME X; RISK ASSESSMENT; RISK FACTORS;

EID: 77953148544     PISSN: 07490690     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cger.2010.02.011     Document Type: Review

References (92)

1. Mazza A.D., Morley J.E. Metabolic syndrome and the older male population. Aging Male 2007, 10:3-8.
2. Grundy S.M. Metabolic syndrome: a multiplex cardiovascular risk factor. J Clin Endocrinol Metab 2007, 92(2):399-404.
3. McDermott M.M. The international pandemic of chronic cardiovascular disease. JAMA 2007, 297:1253-1255.
4. Alberti K.G., Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998, 15:539-553.
5. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Executive summary of the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001, 285:2486-2497.
6. Alberti K.G., Zimmet P., Shaw J. Metabolic syndrome - a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med 2006, 23(5):469-480.
7. Kahn R. The metabolic syndrome (Emperor) wears no clothes. Diabetes Care 2006, 29:1693-1696.
8. Gale E.A. The myth of the metabolic syndrome. Diabetologia 2005, 48:1679-1683.
9. Ferrannini E. Metabolic syndrome: a solution in search of a problem. J Clin Endocrinol Metab 2007, 92:396-398.
10. Reaven G.M. The metabolic syndrome: is this diagnosis necessary?. Am J Clin Nutr 2006, 83:1237-1247.
11. Morley J.E. The metabolic syndrome and aging. J Gerontol A Biol Sci Med Sci 2004, 59:139-142.
12. Alexander C.M., Landsman P.B., Teutsch S.M., et al. NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 2003, 52:1210-1214.
13. Metascreen Writing Committee, Bonadonna R.C., Cucinotta D., et al. The metabolic syndrome is a risk indicator of microvascular and macrovascular complications in diabetes: results from Metascreen, a multicenter diabetes clinic-based survey. Diabetes Care 2006, 29(12):2701-2707.
14. Matsuzawa Y., Shimomura I., Nakamura T., et al. Pathophysiology and pathogenesis of visceral fat obesity. Obes Res 1995, 3(Suppl 2):187s-194s.
15. Henneman P., Aulchenko Y.S., Frants R.R., et al. Prevalence and heritability of the metabolic syndrome and its individual component in a Dutch isolate: the Erasmus Ruephen Family Study. J Med Genet 2008, 45:572.
16. Lin H.F., Boden-Albala B., Juo S.H., et al. Heritabilities of the metabolic syndrome and its components in the Northern Manhattan Family Study. Diabetologia 2005, 48:2006-2012.
17. Lusis A.J., Attie A.D., Reue K. Metabolic syndrome: from epidemiology to systems biology. Nat Rev Genet 2008, 9:819-830.
18. Greenfield J.R., Miller J.W., Keogh J.M., et al. Modulation of blood pressure by central melanocortinergic pathways. N Engl J Med 2009, 360:44-52.
19. Ma L., Tataranni P.A., Bogardus C., et al. Melanocortin 4 receptor gene variation is associated with severe obesity in Pima Indians. Diabetes 2004, 53:2696-2699.
20. Willer C.J., Speliotes E.K., Loos R.J., et al. Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat Genet 2009, 41:25-34.
21. Sui X., Church T.S., Meriwether R.A., et al. Uric acid and the development of metabolic syndrome in women and men. Metabolism 2008, 57:845-852.
22. Kahn R., Buse J., Ferrannini E., et al. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2005, 28:2289-2304.
23. Preiss D., Sattar N. Metabolic syndrome, dysglycaemia and vascular disease: making sense of the evidence. Heart 2007, 93:1493-1496.
24. Stern M.P., Williams K., Gonzalez-Villalpando C., et al. Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease?. Diabetes Care 2004, 27:2676-2681.
25. Shimokata H., Tobin J.D., Muller D.C., et al. Studies in the distribution of body fat: I. Effects of age, sex, and obesity. J Gerontol 1989, 44:M66-M73.
26. Silver A.J., Guillen C.P., Kahl M.J.U., et al. Effect of aging on body fat. J Am Geriatr Soc 1993, 41:211-213.
27. Perry H.M., Horowitz M., Morley J.E., et al. Longitudinal changes in serum 25-hydroxyvitamin D in older people. Metabolism 1999, 48:1028-1032.
28. Morley J.E., Kaiser F.E., Perry H.M., et al. Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men. Metabolism 1997, 46:410-413.
29. Chu L.W., Tam S., Kung A.W., et al. Serum total and bioavailable testosterone levels, central obesity, and muscle strength changes with aging in healthy Chinese men. J Am Geriatr Soc 2008, 56:1286-1291.
30. Wittert G.A., Chapman I.M., Haren M.T., et al. Oral testosterone supplementation increases muscle and decreases fat mass in healthy elderly males with low-normal gonadal status. J Gerontol A Biol Sci Med Sci 2003, 58:618-625.
31. Shahani S., Braga-Basaria M., Basria S. Androgen deprivation therapy in prostate cancer and metabolic risk for atherosclerosis. J Clin Endocrinol Metab 2008, 93:2042-2049.
32. Kapoor D., Malkin C.J., Channer K.S., et al. Androgens, insulin resistance and vascular disease in men. Clin Endocrinol 2005, 63:239-250.
33. Nieschlag E., Swerdloff R., Behre H.M., et al. Investigation, treatment and monitoring of late-onset hypogonadism in males. ISA, ISSAM, and EAU recommendations. Eur Urol 2005, 48:1-4.
34. Morley J.E. Should all long-term care residents receive vitamin D?. J Am Med Dir Assoc 2007, 8:69-70.
35. Hamid Z., Riggs A., Spencer T., et al. Deficiency in residents of academic long-term care facilities despite having been prescribed vitamin D. J Am Med Dir Assoc 2007, 8:71-75.
36. Drinka P.J., Krause P.F., Nest L.J., et al. Determinants of vitamin D levels in nursing home residents. J Am Med Dir Assoc 2007, 8:76-79.
37. Michos E.D., Melamed M.L. Vitamin D and cardiovascular disease risk. Curr Opin Clin Nutr Metab Care 2008, 11:7-12.
38. Lee J.H., O'Keefe J.H., Bell D., et al. Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor?. J Am Coll Cardiol 2008, 52:1949-1956.
39. Pittas A.G., Dawson-Hughes B., Li T., et al. Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care 2006, 29:650-656.
40. Goldbacher E.M., Bromberger J., Matthews K.A. Lifetime history of major depression predicts the development of the metabolic syndrome in middle-aged women. Psychosom Med 2009, 71(3):266-272.
41. Bo S., Rosato R., Ciccone G., et al. What predicts the occurrence of the metabolic syndrome in a population-based cohort of adult healthy subjects?. Diabetes Metab Res Rev 2009, 25(1):76-82.
42. Agyemang C., van Valkengoed I., Hosper K., et al. Educational inequalities in metabolic syndrome vary by ethnic group: evidence from the SUNSET Study. Int J Cardiol 2009, [Epub ahead of print].
43. Hsiao F.C., Wu C.Z., Hsieh C.H., et al. Chinese metabolic syndrome risk score. South Med J 2009, 102(2):159-164.
44. Ferrannini E., Vichi S., Beck-Nielsen H., et al. Insulin action and age. European Group for the Study of Insulin Resistance (EGIR). Diabetes 1996, 45(7):947-953.
45. Barbieri M., Rizzo M.R., Manzella D., et al. Age-related insulin resistance: is it an obligatory finding? The lesson from healthy centenarians. Diabetes Metab Res Rev 2001, 17(1):19-26.
46. Maggi S., Noale M., Galina P., et al. Metabolic syndrome, diabetes, and cardiovascular disease in an elderly Caucasian cohort: the Italian Longitudinal Study on Aging. J Gerontol A Biol Sci Med Sci 2006, 61:505-510.
47. Kotani K., Simohiro H., Adachi S., et al. Relationship between lipoprotein(a), metabolic syndrome, and carotid atherosclerosis in older Japanese people. Gerontology 2008, 54:361-364.
48. McNeill A.M., Katz R., Girman C.J., et al. Metabolic syndrome and cardiovascular disease in older people: the cardiovascular health study. J Am Geriatr Soc 2006, 54:1317-1324.
49. Vogelzangs N., Beekman A.T., Kritchevsky S.B., et al. Psychosocial risk factors and the metabolic syndrome in elderly persons: findings from the Health, Aging and Body Composition Study. J Gerontol A Biol Sci Med Sci 2007, 62:563-569.
50. Mozaffarian D., Kamineni A., Prineas R.J., et al. Metabolic syndrome and mortality in older adults: the Cardiovascular Health Study. Arch Intern Med 2008, 168:969-978.
51. Sattar N., McConnachie A., Shaper A.G., et al. Can metabolic syndrome usefully predict cardiovascular disease and diabetes: outcomes data from two prospective studies. Lancet 2008, 371:1927-1935.
52. Wang J., Ruotsalainen S., Moilanen L., et al. Metabolic syndrome and incident end-stage peripheral vascular disease: a 14-year follow-up study in elderly Finns. Diabetes Care 2007, 30:3099-3104.
53. Wang J., Ruotsalainen S., Moilanen L., et al. The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns. Eur Heart J 2007, 28:857-864.
54. Wang J., Ruotsalainen S., Moilanen L., et al. The metabolic syndrome predicts incident stroke: a 14-year follow-up study in elderly people in Finland. Stroke 2008, 39:1078-1083.
55. Okoro C.A., Zhong Y., Ford E.S., et al. Association between the metabolic syndrome and its components and gait speed among U.S. adults aged 50 years and older: a cross-sectional analysis. BMC Public Health 2006, 6:282.
56. Blaum C.S., West N.A., Haan M.N. Is the metabolic syndrome, with or without diabetes, associated with progressive disability in older Mexican Americans?. J Gerontol A Biol Sci Med Sci 2007, 62:766-773.
57. Penninx B.W., Nicklas B.J., Newman A.B., et al. The Health ABC Study. Metabolic syndrome and physical decline in older persons: results from the Health, Aging and Body Composition Study. J Gerontol A Biol Sci Med Sci 2009, 64(1):96-102.
58. You T., Nicklas Z.B.J., Ding J., et al. The metabolic syndrome is associated with circulating adipokines in older adults across a wide range of adiposity. J Gerontol A Biol Sci Med Sci 2008, 63:414-419.
59. Banks W.A., Willoughby L.M., Thomas D.R., et al. Insulin resistance syndrome in the elderly: assessment of functional, biochemical metabolic, and inflammatory status. Diabetes Care 2007, 30:2369-2373.
60. Yaffe K., Haan M., Blackwell T., et al. Metabolic syndrome and cognitive decline in elderly Latinos: findings from the Sacramento Area Latino Study of Aging Study. J Am Geriatr Soc 2007, 55:758-762.
61. Dore G.A., Elias M.F., Robbins M.A., et al. Relation between central adiposity and cognitive function in the Main-Syracuse Study: attenuation by physical activity. Ann Behav Med 2008, 35:341-350.
62. Yaffe K., Kanaya A., Lindquist K., et al. The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA 2004, 292(18):2237-2242.
63. Gregg E.W., Yaffe K., Cauley J.A., et al. Is diabetes associated with cognitive impairment and cognitive decline among older women? Study of Osteoporotic Fractures Research Group. Arch Intern Med 2000, 160:174-180.
64. Yaffe K., Barrett-Connor E., Lin F., et al. Serum lipoprotein levels, statin use, and cognitive function in older women. Arch Neurol 2002, 59:378-384.
65. Farr S.A., Yamada K.A., Butterfield D.A., et al. Obesity and hypertriglyceridemia produce cognitive impairment. Endocrinology 2008, 149:2628-2636.
66. Basak C., Boot W.R., Voss M.W., et al. Can training in a real-time strategy video game attenuate cognitive decline in older adults?. Psychol Aging 2008, 23:765-777.
67. Morley J.E. The magic of exercise. J Am Med Dir Assoc 2008, 9:375-377.
68. Colberg S.R., Somma C.T., Sechrist S.R. Physical activity participation may offset some of the negative impact of diabetes on cognitive function. J Am Med Dir Assoc 2008, 9:434-438.
69. Rolland Y., Abellan van Kan G., Vellas B. Physical activity and Alzheimer's disease: from prevention to therapeutic perspectives. J Am Med Dir Assoc 2008, 9:390-405.
70. Morley J.E., Perry H.M., Miller D.K. Editorial: something about frailty. J Gerontol A Biol Sci Med Sci 2002, 57:M698-M704.
71. Abellan van Kan G., Rolland Y., Bergman H., et al. The I.A.N.A. Task Force on frailty assessment of older people in clinical practice. J Nutr Health Aging 2008, 12:29-37.
72. Abellan van Kan G., Rolland Y.M., Morley J.E., et al. Frailty: toward a clinical definition. J Am Med Dir Assoc 2008, 9:71-72.
73. Barzilay J.I., Blaum C., Moore T., et al. Insulin resistance and inflammation as precursors of frailty: the Cardiovascular Health Study. Arch Intern Med 2007, 167(7):635-641.
74. de Ruijter W., Westendorp R.G., Assendelft W.J., et al. Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study. BMJ 2009, 338:a3083.
75. De Ruijter W., Assendelft W.J.J., Macfarlane P.W., et al. The additional value of routine-electrocardiograms in cardiovascular risk management of older people. The Leiden 85-plus study: an observational, prospective cohort study. Scand J Prim Health Care 2008, 26:147-153.
76. Viljoen A. Cardiovascular risk estimation - making sense of the numbers. Int J Clin Pract 2008, 62:1300-1303.
77. Sumner A.E., Cowie C.C. Ethnic differences in the ability of triglyceride levels to identify insulin resistance. Atherosclerosis 2008, 196:696-703. Third Report of the National Cholesterol Education Program.
78. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in Adults (Adult Treatment Panel III): final report. Circulation 2002, 106:3143-3421.
79. Yusuf S., Hawken S., Ounpuu S., et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004, 364(9438):937-952.
80. Motta M., Bennati E., Cardillo E., et al. The metabolic syndrome (MS) in the elderly: considerations on the diagnostic criteria of the International Diabetes Federation (IDF) and some proposed modifications. Arch Gerontol Geriatr 2009, 48(3):380-384.
81. Kannel W.B. Coronary heart disease risk factors in the elderly. Am J Geriatr Cardiol 2002, 11:101-107.
82. Zethelius B., Berglund L., Sundström J., et al. Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. N Engl J Med 2008, 358:2107-2116.
83. Williams M.A., Fleg J.L., Ades P.A., et al. American Heart Association Council on Clinical Cardiology Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention. Secondary prevention of coronary heart disease in the elderly (with an emphasis on patients ≥ 75 years of age): an American Heart Association scientific statement from the Council on Clinical Cardiology Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention. Circulation 2002, 105:1735-1743.
84. Brugts J.J., Yetgin T., Hoeks S.E., et al. The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials. BMJ 2009, 338:b2376.
85. Acelajado M.C., Oparil S. Hypertension in the elderly. Clin Geriatr Med 2009, 25(3):391-412.
86. Diabetes in old age 1995, Wiley, Hoboken (NJ), p. 245-64. 3rd edition. A.J. Sinclair, P. Finucane (Eds.).
87. Wannamethee S.G., Shaper A.G., Shincup P.H. Modifiable lifestyle factors and the metabolic syndrome in older men: effects of lifestyle changes. J Am Geriatr Soc 2006, 54:1909-1914.
88. Bianchi G., Rossi V., Muscari A., et al. Physical activity is negatively associated with the metabolic syndrome in the elderly. West J Med 2008, 101:713-721.
89. Morley J.E. Weight loss in older persons: new therapeutic approaches. Curr Pharm Des 2007, 13:3637-3647.
90. Morley J.E. Anorexia and weight loss in older persons. J Gerontol A Biol Sci Med Sci 2003, 58:131-137.
91. Wedick N.M., Barrett-Connor E., Knoke J.D., et al. The relationship between weight loss and all-cause mortality in older men and women with and without diabetes mellitus: the Rancho Bernardo study. J Am Geriatr Soc 2002, 50:1810-1815.
92. Dankner R., Geulayov G., Olmer L., et al. Undetected type 2 diabetes in older adults. Age Ageing 2009, 38(1):56-62.